Rosa Rojo, RN BSN C.D.E. Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 1930 Harrison St Ste 606, Hollywood, FL 33020 Phone: 954-651-5133 Fax: 800-430-9814 |
Ms. Martha Cecilia Small, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 7151 Harding St, Hollywood, FL 33024 Phone: 954-297-1189 Fax: 954-987-1135 |
Kathy Pantuso, RNFA Registered Nurse - Oncology Medicare: Not Enrolled in Medicare Practice Location: 1150 N 35th Ave, Suite 495, Hollywood, FL 33021 Phone: 954-985-5846 Fax: 954-985-2451 |
Ms. Mary Siobhan Mclaughlin, RN BSN BA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1409 Rodman St, Hollywood, FL 33020 Phone: 954-920-7715 |
John Vogan, Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 3501 Johnson St, Hollywood, FL 33021 Phone: 954-265-4545 |
Ifechukwudeny Bishop Okwuoyibo, APRN, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 200 S Park Rd, Hollywood, FL 33021 Phone: 932-727-2983 |
News Archive
Men who experience restless legs syndrome may have a higher risk of dying earlier, according to research that appears in the June 12, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.
CNA recognizes the importance of patient/resident safety and risk management in the evolving world of healthcare. As one of the nation's leading providers of professional liability insurance for healthcare providers and organizations, CNA HealthPro recently published a risk management toolkit, "Special Resource: Protecting Residents, Reducing Liability Exposure - An Aging Services Resource from CNA HealthPro," which offers guidance on clinical, operational, and strategic subjects of concern to aging services providers.
Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.
Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.
The Montreal Heart Institute Research Centre is once again pushing the limits of knowledge in personalized medicine. A meta-analysis combining the results of several pharmacogenomic studies and involving over 40,000 research subjects now makes it possible to demonstrate a different response to statins according to the patient's gene profile.
› Verified 3 days ago